Wireless, needle-implantable biosensor for metabolism
OSCI/Biorasis was formed by Professors Faquir Jain and Fotios Papadimitrakopoulos to commercialize a minimally- invasive glucose and bio-analyte biosensor for use in drug development and eventually in human on-demand metabolic disease management. Biorasis Inc. is currently targeting the drug development and immune suppression/control markets and has a long-term goal of targeting the clinical market.
Ilze Krisst, COO
Faquir Jain, Co-Founder
Fotios Papadimitrakopulos, Co- Founder